AOD 9604 10 mg Rize Up Medical The FDA has repeatedly flagged AOD 9604 as a compound of concern. It was placed on the Category 2 list in 2023 bulk drug substances in compounding that may present significant Not all peptides are restricted. Here's the breakdown you actually need. The FDA's Category 2 classification affects specific compounded peptides BPC 157, TB 500, CJC 1295 Ipamorelin, AOD 9604, Epithalon, Selank, Semax. Others like Sermorelin AOD 9604 Peptide Foundry Premium Research Peptides AOD9604 Peptide for Fat Loss in 2025: LateNight Hype, Quiet Results, and What Nobody Tells You Aod9604 Peptide Fda Approval Status